Cochrane podcast. Nicotine receptors partial agonists: varenicline (Champix, Chantix)
The Cochrane Collaboration issued a podcast reviewing varenicline (Champix, Chantix) and bupropion. They review clinical trials, safety concerns among other relevant aspects. Nicotine receptor partial agonists for smoking cessation Read a related post defining partial agonists.
Varenicline (Champix) psychiatric adverse effects: recommendations to patients from Health Canada
Health Canada has issued an information update about varenicline (Champix), giving some recommendations to patients: Information Update 2009-01 January 6, 2009 For immediate release OTTAWA – Health Canada is reminding Canadians who are taking, or considering taking, the smoking-cessation aid Champix of important safety information for this product. Health Canada is also informing Canadians that […]